# Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER)

> **NCT03665740** · PHASE2 · UNKNOWN · sponsor: **VISN 17 Center of Excellence** · enrollment: 68 (estimated)

## Conditions studied

- Gulf War Illness

## Interventions

- **DRUG:** Resveratrol

## Key facts

- **NCT ID:** NCT03665740
- **Lead sponsor:** VISN 17 Center of Excellence
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2018-09-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03665740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03665740, "Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03665740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*